New treatment for prostate cancer includes early initiation of lutetium-177 prostate-specific membrane antigen (PSMA) radioligand therapy can improve survival in patients with metastatic prostate cancer.
from Medindia Health News https://ift.tt/2tFu09p
No comments:
Post a Comment